FT522-101: A Phase 1 Study of FT522 in Combination with Rituximab in Participants with Relapsed/Refractory BCell Lymphoma
Categories (click each to see list of all clinical trials associated with that category): Cellular Therapy Support Service - Other CAR (ONC), Lymphoma/CLL (ONC)
Current Status: Open
Phase: I (Cancer Control)
Principal Investigator: Lunning, Matthew
Summary